Evommune launches mid-stage trials for immune-modulating drugs targeting skin conditions, backed by $115M funding and led by ex-Dermira executives.

Fact checked by Nick Blackmer Meet the Expert Deeptej Singh, MD, is a board-certified dermatologist in private practice based ...

Phototherapy offers a cost-effective alternative to biologics for treating atopic dermatitis and psoriasis, with significant economic implications. Health plan claims analysis suggests ...

If you have atopic dermatitis (eczema), this guide will help you prepare for what to except during your initial doctor's ...

Atopic dermatitis is an allergy affecting approximately 10% of the Japanese population, with symptoms closely related to ...